Close Menu
    Tripoli WireTripoli Wire
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Tripoli WireTripoli Wire
    Home » South Korea reports more than 100K new COVID-19 cases
    Health

    South Korea reports more than 100K new COVID-19 cases

    July 27, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    South Korea reported 100,285 new COVID-19 infections and 25 deaths in the past 24 hours, the Korea Disease Control and Prevention Agency (KDCA) said. Yonhap News Agency quoted KDCA as saying that the infection toll rose to 19,446,946 and the death toll reached 24,932. According to the KDCA, the daily caseload of 76,379 cases was higher than the 99,327 cases tallied on the previous day, and higher than the 76,379 cases tallied a week earlier.

    South Korea reports more than 100K new COVID-19 casesA daily average of 72,735 confirmed cases was recorded over the past week. There were 532 new cases imported from overseas, bringing the total to 42,683. It is estimated that 177 people are in serious condition, an increase of 9 from yesterday. Twenty-five more deaths have been confirmed, bringing the death toll to 24,932. A fatality rate of 0.13 percent was recorded for the total number of deaths.

    Related Posts

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    DR Congo Ebola death toll tops 1,900 as cases rise

    August 11, 2026

    Obesity linked to 8.2% of Belgium deaths in new health report

    August 8, 2026

    Moderna begins Ebola vaccine trial amid DR Congo outbreak

    August 5, 2026

    Michigan reports first deaths tied to cyclospora outbreak

    August 4, 2026
    Latest News

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    Healthcare shares strengthen market gains
    Healthcare stocks provided another source of support during Wednesday’s session as several pharmaceutical shares recorded large gains. Moderna shares surged 177%, while Merck advanced 12.6% after the companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene with Keytruda following surgical removal of high-risk melanoma. The combination met its primary endpoint for recurrence-free survival. It also met a key secondary endpoint measuring survival without distant cancer spread.

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    South Korea auto exports reach $6.24 billion in July

    August 14, 2026

    Total solar eclipse crosses Russian Arctic and Europe

    August 13, 2026

    International Youth Day 2026 puts youth inclusion in focus

    August 13, 2026
    © 2026 Tripoli Wire | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.